Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ratjen F et al. – Published clinical data show that inhaled tobramycin reduces the bacterial load, improves lung function and reduces the number of hospital admissions. Inhaled tobramycin has been used successfully to eradicate P. aeruginosa in patients with early infection. Maintaining clinical benefits requires chronic tobramycin treatment, and the concept of chronic intermittent inhaled treatment (typically, alternating drug and drug–free periods of 28days) was introduced to minimize the emergence of aminoglycoside resistant P. aeruginosa strains. Other therapeutic advances include the development of different tobramycin formulations and nebulizers that reduce delivery time without compromising efficacy. An optimal treatment regimen for patients with CF with early or intermittent P. aeruginosa infections remains a high priority to maintain long–term lung health.


Related Articles

Diabetes as a Determinant of Mortality in Cystic Fibrosis
Diabetes Care, 11/23/09    Relevance Score: 69%

Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09    Relevance Score: 69%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09    Relevance Score: 69%

Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09    Relevance Score: 69%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 69%

Today in Clinical Pharmacology...keeping you current

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
Diabetic Medicine, 02/09/10

OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
Expert Opinion on Biological Therapy, 02/09/10

Capsaicin jelly against migraine pain
International Journal of Clinical Practice, 02/09/10

Today in Pulmonology...keeping you current

A Follow-up Study of Preterm Infants Given Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants
The Journal of Pediatrics, 02/09/10

Comparing Medical Homes for Children with ADHD and Asthma
Academic Pediatrics, 02/09/10

Adverse childhood experiences are associated with the risk of lung cancer
BMC Public Health, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address